 | • レポートコード：MRC2-11QY11874 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は癲癇診断・治療のグローバル市場について調査・分析したレポートです。種類別（診断（神経学的検査・血液検査・画像診断）、治療（医学・手術））市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別癲癇診断・治療の競争状況、市場シェア ・世界の癲癇診断・治療市場：種類別市場規模 2015年-2020年（診断（神経学的検査・血液検査・画像診断）、治療（医学・手術）） ・世界の癲癇診断・治療市場：種類別市場規模予測 2021年-2026年（診断（神経学的検査・血液検査・画像診断）、治療（医学・手術）） ・世界の癲癇診断・治療市場：用途別市場規模 2015年-2020年（病院、クリニック） ・世界の癲癇診断・治療市場：用途別市場規模予測 2021年-2026年（病院、クリニック） ・北米の癲癇診断・治療市場分析：米国、カナダ ・ヨーロッパの癲癇診断・治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの癲癇診断・治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の癲癇診断・治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの癲癇診断・治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、Johnson & Johnson、UCB Pharma、Abbott、GlaxoSmithKline、Novartis、Sanofi、Takeda、Medtronic、Natus Medical、Siemens ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Epilepsy is a neurological disorder affecting the central nervous system. In this medical condition, the brain exhibits abnormal activity, which results in periods of unusual behavior or seizures and sometimes, loss of awareness. Temporary confusion, anxiety, uncontrollable jerking movements of the arms and legs, and others are some of the common symptoms of the disease.
Increasing prevalence of epilepsy is a major driver for the market. According to a report by the World Health Organization (2018), about 50 million people across the world are estimated to suffer from epilepsy, making it one of the most common neurological diseases. In addition, the report states that the total number of people aged 65 or more is projected to increase from 524 million in 2010 to approximately 1.5 billion by 2050.
Market Analysis and Insights: Global Epilepsy Diagnosis & Treatment Market
The global Epilepsy Diagnosis & Treatment market size is projected to reach US$ 9065.6 million by 2026, from US$ 7778.7 million in 2020, at a CAGR of 15.0%% during 2021-2026.
Global Epilepsy Diagnosis & Treatment Scope and Market Size
Epilepsy Diagnosis & Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Epilepsy Diagnosis & Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Pfizer
Johnson & Johnson
UCB Pharma
Abbott
GlaxoSmithKline
Novartis
Sanofi
Takeda
Medtronic
Natus Medical
Siemens
Market segment by Type, the product can be split into
Diagnosis (Neurological Exam, Blood Test, Imaging)
Treatment (Medication, Surgery)
Market segment by Application, split into
Hospitals
Clinics
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Epilepsy Diagnosis & Treatment Revenue
1.4 Market by Type
1.4.1 Global Epilepsy Diagnosis & Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Diagnosis (Neurological Exam, Blood Test, Imaging)
1.4.3 Treatment (Medication, Surgery)
1.5 Market by Application
1.5.1 Global Epilepsy Diagnosis & Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Epilepsy Diagnosis & Treatment Market Perspective (2015-2026)
2.2 Global Epilepsy Diagnosis & Treatment Growth Trends by Regions
2.2.1 Epilepsy Diagnosis & Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Epilepsy Diagnosis & Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Epilepsy Diagnosis & Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Epilepsy Diagnosis & Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Epilepsy Diagnosis & Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Epilepsy Diagnosis & Treatment Players by Market Size
3.1.1 Global Top Epilepsy Diagnosis & Treatment Players by Revenue (2015-2020)
3.1.2 Global Epilepsy Diagnosis & Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Epilepsy Diagnosis & Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Epilepsy Diagnosis & Treatment Market Concentration Ratio
3.2.1 Global Epilepsy Diagnosis & Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Epilepsy Diagnosis & Treatment Revenue in 2019
3.3 Epilepsy Diagnosis & Treatment Key Players Head office and Area Served
3.4 Key Players Epilepsy Diagnosis & Treatment Product Solution and Service
3.5 Date of Enter into Epilepsy Diagnosis & Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Epilepsy Diagnosis & Treatment Historic Market Size by Type (2015-2020)
4.2 Global Epilepsy Diagnosis & Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Epilepsy Diagnosis & Treatment Market Size by Application (2015-2020)
5.2 Global Epilepsy Diagnosis & Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Epilepsy Diagnosis & Treatment Market Size (2015-2020)
6.2 Epilepsy Diagnosis & Treatment Key Players in North America (2019-2020)
6.3 North America Epilepsy Diagnosis & Treatment Market Size by Type (2015-2020)
6.4 North America Epilepsy Diagnosis & Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Epilepsy Diagnosis & Treatment Market Size (2015-2020)
7.2 Epilepsy Diagnosis & Treatment Key Players in Europe (2019-2020)
7.3 Europe Epilepsy Diagnosis & Treatment Market Size by Type (2015-2020)
7.4 Europe Epilepsy Diagnosis & Treatment Market Size by Application (2015-2020)
8 China
8.1 China Epilepsy Diagnosis & Treatment Market Size (2015-2020)
8.2 Epilepsy Diagnosis & Treatment Key Players in China (2019-2020)
8.3 China Epilepsy Diagnosis & Treatment Market Size by Type (2015-2020)
8.4 China Epilepsy Diagnosis & Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Epilepsy Diagnosis & Treatment Market Size (2015-2020)
9.2 Epilepsy Diagnosis & Treatment Key Players in Japan (2019-2020)
9.3 Japan Epilepsy Diagnosis & Treatment Market Size by Type (2015-2020)
9.4 Japan Epilepsy Diagnosis & Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Epilepsy Diagnosis & Treatment Market Size (2015-2020)
10.2 Epilepsy Diagnosis & Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Epilepsy Diagnosis & Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Epilepsy Diagnosis & Treatment Market Size by Application (2015-2020)
11 India
11.1 India Epilepsy Diagnosis & Treatment Market Size (2015-2020)
11.2 Epilepsy Diagnosis & Treatment Key Players in India (2019-2020)
11.3 India Epilepsy Diagnosis & Treatment Market Size by Type (2015-2020)
11.4 India Epilepsy Diagnosis & Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Epilepsy Diagnosis & Treatment Market Size (2015-2020)
12.2 Epilepsy Diagnosis & Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Epilepsy Diagnosis & Treatment Market Size by Type (2015-2020)
12.4 Central & South America Epilepsy Diagnosis & Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Epilepsy Diagnosis & Treatment Introduction
13.1.4 Pfizer Revenue in Epilepsy Diagnosis & Treatment Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Details
13.2.2 Johnson & Johnson Business Overview
13.2.3 Johnson & Johnson Epilepsy Diagnosis & Treatment Introduction
13.2.4 Johnson & Johnson Revenue in Epilepsy Diagnosis & Treatment Business (2015-2020)
13.2.5 Johnson & Johnson Recent Development
13.3 UCB Pharma
13.3.1 UCB Pharma Company Details
13.3.2 UCB Pharma Business Overview
13.3.3 UCB Pharma Epilepsy Diagnosis & Treatment Introduction
13.3.4 UCB Pharma Revenue in Epilepsy Diagnosis & Treatment Business (2015-2020)
13.3.5 UCB Pharma Recent Development
13.4 Abbott
13.4.1 Abbott Company Details
13.4.2 Abbott Business Overview
13.4.3 Abbott Epilepsy Diagnosis & Treatment Introduction
13.4.4 Abbott Revenue in Epilepsy Diagnosis & Treatment Business (2015-2020)
13.4.5 Abbott Recent Development
13.5 GlaxoSmithKline
13.5.1 GlaxoSmithKline Company Details
13.5.2 GlaxoSmithKline Business Overview
13.5.3 GlaxoSmithKline Epilepsy Diagnosis & Treatment Introduction
13.5.4 GlaxoSmithKline Revenue in Epilepsy Diagnosis & Treatment Business (2015-2020)
13.5.5 GlaxoSmithKline Recent Development
13.6 Novartis
13.6.1 Novartis Company Details
13.6.2 Novartis Business Overview
13.6.3 Novartis Epilepsy Diagnosis & Treatment Introduction
13.6.4 Novartis Revenue in Epilepsy Diagnosis & Treatment Business (2015-2020)
13.6.5 Novartis Recent Development
13.7 Sanofi
13.7.1 Sanofi Company Details
13.7.2 Sanofi Business Overview
13.7.3 Sanofi Epilepsy Diagnosis & Treatment Introduction
13.7.4 Sanofi Revenue in Epilepsy Diagnosis & Treatment Business (2015-2020)
13.7.5 Sanofi Recent Development
13.8 Takeda
13.8.1 Takeda Company Details
13.8.2 Takeda Business Overview
13.8.3 Takeda Epilepsy Diagnosis & Treatment Introduction
13.8.4 Takeda Revenue in Epilepsy Diagnosis & Treatment Business (2015-2020)
13.8.5 Takeda Recent Development
13.9 Medtronic
13.9.1 Medtronic Company Details
13.9.2 Medtronic Business Overview
13.9.3 Medtronic Epilepsy Diagnosis & Treatment Introduction
13.9.4 Medtronic Revenue in Epilepsy Diagnosis & Treatment Business (2015-2020)
13.9.5 Medtronic Recent Development
13.10 Natus Medical
13.10.1 Natus Medical Company Details
13.10.2 Natus Medical Business Overview
13.10.3 Natus Medical Epilepsy Diagnosis & Treatment Introduction
13.10.4 Natus Medical Revenue in Epilepsy Diagnosis & Treatment Business (2015-2020)
13.10.5 Natus Medical Recent Development
13.11 Siemens
10.11.1 Siemens Company Details
10.11.2 Siemens Business Overview
10.11.3 Siemens Epilepsy Diagnosis & Treatment Introduction
10.11.4 Siemens Revenue in Epilepsy Diagnosis & Treatment Business (2015-2020)
10.11.5 Siemens Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Epilepsy Diagnosis & Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Epilepsy Diagnosis & Treatment Revenue
Table 3. Ranking of Global Top Epilepsy Diagnosis & Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Epilepsy Diagnosis & Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Diagnosis (Neurological Exam, Blood Test, Imaging)
Table 6. Key Players of Treatment (Medication, Surgery)
Table 7. Global Epilepsy Diagnosis & Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Epilepsy Diagnosis & Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Epilepsy Diagnosis & Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Epilepsy Diagnosis & Treatment Market Share by Regions (2015-2020)
Table 11. Global Epilepsy Diagnosis & Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Epilepsy Diagnosis & Treatment Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Epilepsy Diagnosis & Treatment Market Growth Strategy
Table 17. Main Points Interviewed from Key Epilepsy Diagnosis & Treatment Players
Table 18. Global Epilepsy Diagnosis & Treatment Revenue by Players (2015-2020) (Million US$)
Table 19. Global Epilepsy Diagnosis & Treatment Market Share by Players (2015-2020)
Table 20. Global Top Epilepsy Diagnosis & Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epilepsy Diagnosis & Treatment as of 2019)
Table 21. Global Epilepsy Diagnosis & Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Epilepsy Diagnosis & Treatment Product Solution and Service
Table 24. Date of Enter into Epilepsy Diagnosis & Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Epilepsy Diagnosis & Treatment Market Size by Type (2015-2020) (Million US$)
Table 27. Global Epilepsy Diagnosis & Treatment Market Size Share by Type (2015-2020)
Table 28. Global Epilepsy Diagnosis & Treatment Revenue Market Share by Type (2021-2026)
Table 29. Global Epilepsy Diagnosis & Treatment Market Size Share by Application (2015-2020)
Table 30. Global Epilepsy Diagnosis & Treatment Market Size by Application (2015-2020) (Million US$)
Table 31. Global Epilepsy Diagnosis & Treatment Market Size Share by Application (2021-2026)
Table 32. North America Key Players Epilepsy Diagnosis & Treatment Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Epilepsy Diagnosis & Treatment Market Share (2019-2020)
Table 34. North America Epilepsy Diagnosis & Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. North America Epilepsy Diagnosis & Treatment Market Share by Type (2015-2020)
Table 36. North America Epilepsy Diagnosis & Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. North America Epilepsy Diagnosis & Treatment Market Share by Application (2015-2020)
Table 38. Europe Key Players Epilepsy Diagnosis & Treatment Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Epilepsy Diagnosis & Treatment Market Share (2019-2020)
Table 40. Europe Epilepsy Diagnosis & Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Epilepsy Diagnosis & Treatment Market Share by Type (2015-2020)
Table 42. Europe Epilepsy Diagnosis & Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Epilepsy Diagnosis & Treatment Market Share by Application (2015-2020)
Table 44. China Key Players Epilepsy Diagnosis & Treatment Revenue (2019-2020) (Million US$)
Table 45. China Key Players Epilepsy Diagnosis & Treatment Market Share (2019-2020)
Table 46. China Epilepsy Diagnosis & Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. China Epilepsy Diagnosis & Treatment Market Share by Type (2015-2020)
Table 48. China Epilepsy Diagnosis & Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. China Epilepsy Diagnosis & Treatment Market Share by Application (2015-2020)
Table 50. Japan Key Players Epilepsy Diagnosis & Treatment Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Epilepsy Diagnosis & Treatment Market Share (2019-2020)
Table 52. Japan Epilepsy Diagnosis & Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Epilepsy Diagnosis & Treatment Market Share by Type (2015-2020)
Table 54. Japan Epilepsy Diagnosis & Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Epilepsy Diagnosis & Treatment Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Epilepsy Diagnosis & Treatment Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Epilepsy Diagnosis & Treatment Market Share (2019-2020)
Table 58. Southeast Asia Epilepsy Diagnosis & Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Epilepsy Diagnosis & Treatment Market Share by Type (2015-2020)
Table 60. Southeast Asia Epilepsy Diagnosis & Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Epilepsy Diagnosis & Treatment Market Share by Application (2015-2020)
Table 62. India Key Players Epilepsy Diagnosis & Treatment Revenue (2019-2020) (Million US$)
Table 63. India Key Players Epilepsy Diagnosis & Treatment Market Share (2019-2020)
Table 64. India Epilepsy Diagnosis & Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. India Epilepsy Diagnosis & Treatment Market Share by Type (2015-2020)
Table 66. India Epilepsy Diagnosis & Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. India Epilepsy Diagnosis & Treatment Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Epilepsy Diagnosis & Treatment Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Epilepsy Diagnosis & Treatment Market Share (2019-2020)
Table 70. Central & South America Epilepsy Diagnosis & Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Epilepsy Diagnosis & Treatment Market Share by Type (2015-2020)
Table 72. Central & South America Epilepsy Diagnosis & Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Epilepsy Diagnosis & Treatment Market Share by Application (2015-2020)
Table 74. Pfizer Company Details
Table 75. Pfizer Business Overview
Table 76. Pfizer Product
Table 77. Pfizer Revenue in Epilepsy Diagnosis & Treatment Business (2015-2020) (Million US$)
Table 78. Pfizer Recent Development
Table 79. Johnson & Johnson Company Details
Table 80. Johnson & Johnson Business Overview
Table 81. Johnson & Johnson Product
Table 82. Johnson & Johnson Revenue in Epilepsy Diagnosis & Treatment Business (2015-2020) (Million US$)
Table 83. Johnson & Johnson Recent Development
Table 84. UCB Pharma Company Details
Table 85. UCB Pharma Business Overview
Table 86. UCB Pharma Product
Table 87. UCB Pharma Revenue in Epilepsy Diagnosis & Treatment Business (2015-2020) (Million US$)
Table 88. UCB Pharma Recent Development
Table 89. Abbott Company Details
Table 90. Abbott Business Overview
Table 91. Abbott Product
Table 92. Abbott Revenue in Epilepsy Diagnosis & Treatment Business (2015-2020) (Million US$)
Table 93. Abbott Recent Development
Table 94. GlaxoSmithKline Company Details
Table 95. GlaxoSmithKline Business Overview
Table 96. GlaxoSmithKline Product
Table 97. GlaxoSmithKline Revenue in Epilepsy Diagnosis & Treatment Business (2015-2020) (Million US$)
Table 98. GlaxoSmithKline Recent Development
Table 99. Novartis Company Details
Table 100. Novartis Business Overview
Table 101. Novartis Product
Table 102. Novartis Revenue in Epilepsy Diagnosis & Treatment Business (2015-2020) (Million US$)
Table 103. Novartis Recent Development
Table 104. Sanofi Company Details
Table 105. Sanofi Business Overview
Table 106. Sanofi Product
Table 107. Sanofi Revenue in Epilepsy Diagnosis & Treatment Business (2015-2020) (Million US$)
Table 108. Sanofi Recent Development
Table 109. Takeda Business Overview
Table 110. Takeda Product
Table 111. Takeda Company Details
Table 112. Takeda Revenue in Epilepsy Diagnosis & Treatment Business (2015-2020) (Million US$)
Table 113. Takeda Recent Development
Table 114. Medtronic Company Details
Table 115. Medtronic Business Overview
Table 116. Medtronic Product
Table 117. Medtronic Revenue in Epilepsy Diagnosis & Treatment Business (2015-2020) (Million US$)
Table 118. Medtronic Recent Development
Table 119. Natus Medical Company Details
Table 120. Natus Medical Business Overview
Table 121. Natus Medical Product
Table 122. Natus Medical Revenue in Epilepsy Diagnosis & Treatment Business (2015-2020) (Million US$)
Table 123. Natus Medical Recent Development
Table 124. Siemens Company Details
Table 125. Siemens Business Overview
Table 126. Siemens Product
Table 127. Siemens Revenue in Epilepsy Diagnosis & Treatment Business (2015-2020) (Million US$)
Table 128. Siemens Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Epilepsy Diagnosis & Treatment Market Share by Type: 2020 VS 2026
Figure 2. Diagnosis (Neurological Exam, Blood Test, Imaging) Features
Figure 3. Treatment (Medication, Surgery) Features
Figure 4. Global Epilepsy Diagnosis & Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Epilepsy Diagnosis & Treatment Report Years Considered
Figure 8. Global Epilepsy Diagnosis & Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Epilepsy Diagnosis & Treatment Market Share by Regions: 2020 VS 2026
Figure 10. Global Epilepsy Diagnosis & Treatment Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Epilepsy Diagnosis & Treatment Market Share by Players in 2019
Figure 13. Global Top Epilepsy Diagnosis & Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epilepsy Diagnosis & Treatment as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Epilepsy Diagnosis & Treatment Revenue in 2019
Figure 15. North America Epilepsy Diagnosis & Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Epilepsy Diagnosis & Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Epilepsy Diagnosis & Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Epilepsy Diagnosis & Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Epilepsy Diagnosis & Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Epilepsy Diagnosis & Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Epilepsy Diagnosis & Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed
髄膜炎診断・治療の世界市場（～2026年） Meningitis is an acute inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges. The most common symptoms are fever, headache, and neck stiffness. Other symptoms include confusion or altered consciousness, vomiting, and an inability to tolerate …- HIV診断・治療の世界市場（～2026年） HIV prevalence in Africa, specifically in Southern region is very high as compared to North African region. Approximately 1 out of 4 is suffering from HIV. Southern and Eastern region of Africa has one of the highest prevalence rate of HIV, about 19 million people have HIV. While HIV prevalence is l…
- ミトコンドリアミオパチー診断・治療の世界市場（～2026年） Mitochondrial myopathies are types of myopathies associated with mitochondrial disease. On biopsy, the muscle tissue of patients with these diseases usually demonstrate "ragged red" muscle fibers. These ragged-red fibers contain mild accumulations of glycogen and neutral lipids, and may show an incr…
- クラミジア診断・治療の世界市場（～2026年） Chlamydia trachomatis is a type of sexually transmitted disease that is prevalent in population of all age group, but women are much more vulnerable to it. The Chlamydia diagnosis involves a series of test such as urine culture, The change in lifestyle especially related to sex preferences is the ma…
- 十字靭帯診断・治療の世界市場（～2026年） A ligament is a band of tissue that holds the bones together, keeping the knee stable. Primarily these ligaments are broadly classified into cruciate ligament and collateral ligament. Further, these are divided into four primary ligaments, namely, Anterior Cruciate Ligament (ACL), Posterior Cruciate…